相关产品推荐更多 >

EZElisa™猴选择素P(SELP)ELISA试剂盒-EZElisa™ Monkey Selectin P (SELP) ELISA Kit
询价
Canine Mucin-7 ELISA Kit/Canine Mucin-7 ELISA Kit
询价
EZElisa™ 小鼠Prostaglandin E2(PGE2)ELISA试剂盒-EZElisa™ Mouse Prostaglandin E2 (PGE2) ELISA Kit
询价
Cavy Coagulation Factor X ELISA Kit/Cavy Coagulation Factor X ELISA Kit
询价
EZElisa™小鼠抗苗勒管激素抗体(抗AMH)ELISA试剂盒-EZElisa™ Mouse Anti-Anti-Mullerian Hormone Antibody (Anti-AMH) ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
运输过程中保存:2-8℃
- 保质期:
1年
- 英文名:
EZElisa™ Human Plasminogen Activator Urokinase (uPA) ELISA Kit
- 库存:
100
- 供应商:
艾美捷科技
EZElisa™人纤溶酶原激活物尿激酶(uPA)ELISA试剂盒,EZElisa™ Human Plasminogen Activator Urokinase (uPA) ELISA Kit,纤溶酶原激活物尿激酶(uPA)ELISA试剂盒, Plasminogen Activator Urokinase (uPA) ELISA Kit
产品名称:EZElisa™人Netrin受体UNC5D(UNC5D)ELISA试剂盒-EZElisa™ Human Plasminogen Activator Urokinase (uPA) ELISA Kit
产品货号:A-QEK00629-96wells
产品规格:96wells

Enzyme Immunoassay for the estimation of Human Plasminogen Activator Urokinase (uPA) ELISA in serum and plasma, tissue homogenates and other biological fluids.
种属:Human
检测方法:比色法
检测范围:15.6 - 1,000 pg/ml

该EZElisa™人纤溶酶原激活物尿激酶(uPA)ELISA试剂盒ELISA的特点包括:即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证,符合金环标准质量ELISA的要求,这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物,样品可以是血清

运输过程中保存:2-8℃
点击:EZElisa™人Netrin受体UNC5D(UNC5D)ELISA试剂盒-EZElisa™ Human Plasminogen Activator Urokinase (uPA) ELISA Kit更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验RFLP Molecular Analysis of the Urokinase-Type Plasminogen Activator Gene
attachments. One such enzyme, the serine protease urokinase-type plasminogen activator (uPA), converts enzymatically inactive plasminogen into the widely acting protease plasmin, which degrades several extracellular matrix components and also activates
as the Northern blot (2 ). Both are, then, often key elements in establishing the identity of nucleic acids of interest. Northern blot analysis was used by us as a tool in order to answer the question whether or not the nuclear transcripitional apparatus of human
is almost catalytic when compared to antisense silencing. Of these targets, the uPAR-uPA system and MMPs holds great promise. Targeting uPA/uPAR may provide additive or synergistic treatment benefits if used in combination with conventional therapeutics
技术资料暂无技术资料 索取技术资料




